STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Shares outstanding
STERIS plc's shares outstanding at the end of fiscal 2026 was $98.7M, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was $97.6M. Over the past ten years it has ranged from $60.0M (fiscal 2015) to $100.2M (fiscal 2023); the current reading is higher than 75% of that period. STERIS plc ranks 32nd of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $98.7M | (0.40%) |
| FY2025 | $99.1M | (0.30%) |
| FY2024 | $99.4M | (0.84%) |
| FY2023 | $100.2M | 1.95% |
| FY2022 | $98.3M | 14.47% |
| FY2021 | $85.9M | 0.30% |
| FY2020 | $85.6M | 0.20% |
| FY2019 | $85.5M | (0.29%) |
| FY2018 | $85.7M | (0.44%) |
| FY2017 | $86.1M | 20.95% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $97.6M | (0.31%) |
| Jun 2026 | $97.9M | (0.81%) |
| Mar 2026 | $98.7M | 0.10% |
| Dec 2025 | $98.6M | (0.20%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PHG Koninklijke Philips N.V. compare | $989.9M |
| GEHC GE HealthCare Technologies Inc. compare | $453.0M |
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| DXCM DexCom, Inc. compare | $383.5M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $191.4M |
| GMED Globus Medical, Inc. compare | $136.0M |
| STE STERIS plc | $97.6M |
| GKOS Glaukos Corporation compare | $61.2M |
| PEN Penumbra, Inc. compare | $39.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement